When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ABCL - F-star Therapeutics: New Biologics Platform For Immunotherapy
AbCellera Biologics Inc.
F-star's antibody engineering platform is seemingly undervalued with comparable companies worth billions of dollars in equity value.
The company has an exciting pipeline of early immuno-therapy clinical assets from F-star's recent pivot, 2 years ago, to internal drug development.
Potential to close larger developmental deals from its platform and pipeline and the blockbuster potential of these drug candidates, make F-star a compelling long-term investment.